Related Experiment Videos

Optimal blood pressure control after coronary events: the challenge remains

Elise Sverre1, Kari Peersen2, Jan Erik Otterstad2

  • 1Department of Medicine, Drammen Hospital, Vestre Viken Trust, Drammen, Norway; Department of Behavioral Sciences in Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Insights

Poor blood pressure control is common after heart events, linked to diabetes and obesity. Medication use decreased post-discharge, indicating suboptimal treatment for hypertension.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Public Health

Background:

  • Suboptimal blood pressure (BP) control remains a significant challenge in patients post-myocardial infarction (MI) or coronary revascularization.
  • Identifying factors associated with unfavorable BP control is crucial for improving patient outcomes and reducing cardiovascular event recurrence.

Purpose of the Study:

  • To identify sociodemographic, medical, and psychosocial factors associated with unfavorable BP control in patients hospitalized with MI and/or coronary revascularization.
  • To assess the trends in BP-lowering medication prescription from hospital discharge to follow-up.

Main Methods:

  • Cross-sectional study of 1012 patients with data collected from hospital records, questionnaires, clinical exams, and blood samples.
  • Follow-up duration ranged from 2-36 months (mean 17 months).
  • Statistical analyses included adjusted and linear regression models to identify predictors of unfavorable BP control.

Main Results:

  • Forty-six percent of patients exhibited unfavorable BP control (≥140/90 mm Hg, or ≥80 mm Hg for diabetics) at follow-up.
  • Diabetes (OR 2.4), higher body mass index (OR 1.05 per 1.0 kg/m²), and older age (OR 1.04 per year) were significantly associated with unfavorable BP control.
  • A significant decrease in the proportion of patients treated with angiotensin inhibitors and beta-blockers was observed from discharge to follow-up (P < .001).

Conclusions:

  • Blood pressure control is insufficient following coronary events, with obesity and diabetes being key associated factors.
  • The prescription of BP-lowering drugs appears suboptimal, with a notable decrease in the use of essential antihypertensive medications.
  • Targeting overweight and intensifying pharmacologic treatment are critical strategies to enhance BP control in this patient population.

Related Concept Videos